Repro-Med Systems (OTC:REPR) emerged victorious as the US Court of Appeals for the Federal Circuit denied an appeal from competitor EMed Technologies in a patent spat over protective needle-stick related technology. In the original case, Repro-Med claimed that a patent EMed owned related to “protection to eliminate needle stick injuries when using needles associated with subcutaneous […]
EMED Technologies
EMED seeks injunction against ReproMed
EMED Technologies said today that it is seeking a federal court injunction against competitor Repro-Med Systems to keep the company from selling home infusion pumps and needles for subcutaneous immunoglobulin infusion. The company has retained Houston-based Hicks Thomas LLP in seeking the injunction, which it said is being carried out after the FDA determined the […]